Register Today

Register

Share your news with us and we will share it in BioLink and on MichBio’s social media channels. Reach over 17,000 people in the Bio-Industry.

Join the Innovation Team at Healthmark Industries!

Now hiring – Manager of R&D Testing | Fraser, MI

Are you a scientific leader ready to make an impact? Healthmark Industries is seeking a dynamic Manager of R&D Testing to spearhead innovation and excellence in our research and development efforts. 

In this key leadership role, you’ll: 

• Provide scientific and technical direction for groundbreaking projects.
• Inspire and develop a talented team of R&D professionals. 
• Oversee the daily operations of our cutting-edge laboratory group.
• Drive forward-thinking solutions in a fast-paced, collaborative environment.

This is more than a management role — it’s a chance to shape the future of healthcare innovation. 

Ready to lead, innovate, and grow with us? Apply today and make a difference! 

Co-Founder of Velesco Pharmaceuticals Joins TSRL Board of Directors

TSRL, Inc., a preclinical CRO based in Ann Arbor, has appointed Gerry Cox to its Board of Directors. Cox, Co-Founder and former COO of Velesco Pharmaceuticals, brings more than 30 years of leadership experience from roles at Pfizer, Velesco, and Pace Analytical Life Sciences. 

His appointment strengthens TSRL’s strategic growth efforts and expands its connections to the East Coast life sciences ecosystem. TSRL continues to build its reputation as a trusted partner in early-stage drug development, guided by a board of leaders from across industry and academia. 

>> LEARN MORE 

CABRI Opens Applications for Undergraduate Research Fellowships

The Cayman Biomedical Research Institute (CABRI) is now accepting applications for its 2025 undergraduate research fellowships. Open from August 11 through September 29, the program provides up to $5,000 per academic year to support student-mentor research teams. Awards may be used as compensation for undergraduates or for essential project reagents. 

The fellowship aims to foster the next generation of scientific leaders, building on CABRI’s 2024 awards that supported projects in cancer biology, cell metabolism, and neuroscience. 

>> LEARN MORE 

SciTech Development Clinical Trials Shows Breakthrough Results

SciTech Development announced that its Convertible Notes Round #3 has been oversubscribed, raising $4.27M, well above the $3M target. The company’s T-cell NHL clinical trial of ST-001 nanoFenretinide™ is showing extraordinary outcomes, including a 100% Disease Control Rate at the two highest dose levels and multiple patients achieving Partial Responses.

These results validate both safety and clinical activity, with patients reporting minimal side effects and many choosing to continue in the trial. SciTech credits stron early data and investor support for making 2025 a breakout year.

TrialAssure’s Zach Weingarden to Speak on AI in Drug Development at RAPS Convergence 2025

Zach Weingarden, MS, Director of AI Technology & Applications at TrialAssure, has been selected to present at RAPS Convergence 2025 in Pittsburgh. He will join a panel of industry leaders discussing “Embracing the Age of Generative AI in Drug Development” on October 8. The session will explore how AI is transforming regulatory intelligence, clinical development, and patient outcomes. 

TrialAssure has integrated AI across its solutions—including LINK AI®, ANONYMIZE®, and REGISTRY®—to help sponsors and regulatory teams streamline processes and enhance compliance. 

>> LEARN MORE 

SBIR/STTR Programs Face Urgent Need for Reauthorization

MichBio has joined a national coalition of bioscience associations urging Congress to swiftly reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs before their September 30 expiration. These long-standing initiatives provide critical early-stage funding that drives innovation, supports startups, and fuels breakthroughs in biotech, diagnostics, pharmaceuticals, and medical devices. Without timely renewal, entrepreneurs could face major uncertainty, jeopardizing innovation and patient care nationwide.

Approach to Federal Grantmaking Takes Worrisome Turn

A new Executive Order issued August 7, 2025, introduces sweeping changes to federal grantmaking, requiring political approval of all discretionary grants and tying awards to presidential policy priorities. The order allows agencies to cancel grants midstream, restricts indirect cost reimbursements, and pauses new grant announcements until compliance systems are in place. Experts warn these measures threaten scientific independence, disrupt ongoing research, and create uncertainty for universities, labs, and innovators. MichBio emphasizes the importance of safeguarding merit-based funding to protect research integrity and innovation.

>> Inside Ann Arbor’s Life Sciences Boom

>> WMU Secures $5.3M to Boost Michigan Innovation and Biotech Growth

>> Private Equity Firms Spot a Healthcare Value Play in Contract Manufacturing 

>> EU Approves Gilead’s New Injection for Preventing HIV 

>> Novo Nordisk Looks to Next Generation of Obesity, Diabetes Drugs with $550M Replicate Research Deal

MichBio Visits UP North Life Sciences Community

MichBio’s annual visit to the Upper Peninsula highlighted the region’s growing strength in life sciences, advanced manufacturing, and workforce development. Stops included Michigan Tech’s nationally ranked Biomedical and Chemical Engineering programs and the new H-STEM Complex, Northern Michigan University’s revitalized Jacobetti Complex for technical training, and Marquette’s expanding medical device cluster led by Able Medical Devices. The tour wrapped up with a well-attended BioMixer at Blackrocks Brewery, celebrating the innovation and collaboration fueling Michigan’s life sciences across the state.

Building Connections, Driving Innovation: Networking Through MichBio

Wed., Sept. 10 | 5:00-7:00 PM

Plymouth Green Tech. Center

3600 Green Ct., Ann Arbor

Members – Free;

Non-members – $10

Join MichBio and Ann Arbor SPARK for an evening of insightful discussion, networking, and industry connections at the heart of Michigan’s life sciences community.

Special Fireside Chat with Alan Vanderborght Founder & CEO, KYBORA

In this exclusive conversation, Alan will share:

• Innovative approaches to deal-making and capital strategy
• How to navigate today’s challenging funding environment
• Insights from his global experience in biotech, pharma, and health tech

BioMixer – Traverse City

Thurs., Oct. 16 | 5:00-7:00 PM

Bonobo Winery

12011 Center Rd., Traverse City

No cost for all attendees

Hosted by MichBio and Avantor, BioMixer is the perfect chance to meet and mingle with Life Sciences professionals, academics, and students from across the industry. Whether you’re looking to explore new ideas, strengthen your network, or just enjoy connecting with like-minded individuals, there’s a place for you here.

Member Exclusive:

Get the Latest GBG Report – Packed with Opportunities

The August GBG report features 78 new non-dilutive funding opportunities, notices of special interest, and recurring programs across diverse research areas, including rare diseases, women’s health, infectious disease, cancer, and AI/ML. Highlights include USDA NIFA grants, DARPA’s MASH initiative, the BARDA Project BioShield, and multiple opportunities from the FDA and PCORI.

>> Access the Report (Members Only)

Below are upcoming industry events. Click here to view all events.

MichBio members receive an additional discount on Partner Events. Deadline dates do apply and are listed on the discount page. Log in to your membership account to access discount codes/directions.

INDUSTRY EVENT

A2 BioSocial September

Sept. 9, 2025

Ann Arbor, MI

MB NETWORKING EVENT

BioArbor – September 2025

Sept. 10, 2025

Ann Arbor, MI

INDUSTRY EVENT

Harvest of Hope Gala

Sept. 20, 2025

Livonia, MI

INDUSTRY EVENT

Innovation Partnerships Celebrate Innovation

Sept. 24, 2025

Ann Arbor, MI

MB SIGNATURE EVENT

Michigan Medical Device Summit

Sept. 25, 2025

Grand Rapids, MI

PARTNER EVENT

MDMA 2025 Virtual Executive Forum

Sept. 26, 2025

Virtual

MB WEBINAR

Integrated Regulatory and Reimbursement Pathways for Commercial Acceleration

Sept. 30, 2025

Virtual

INDUSTRY EVENT

Fall UnDemo Day®

Oct. 1, 2025

Detroit, MI

PARTNER EVENT

The MedTech Conference*

Oct. 5-8, 2025

San Diego, CA

PARTNER EVENT

BioFuture 2025*

Oct. 13-15, 2025

New York City, NY

MB WEBINAR

Patent Application Strategies: Drafting Tips. Filing Insights. Long-Term IP Success

Oct. 15, 2025

Virtual

MB NETWORKING EVENT

BioMixer Traverse City

Oct. 16, 2025

Traverse City, MI

MB SIGNATURE EVENT

Drug Discovery & Development Symposium

Oct. 20, 2025

Ann Arbor, MI

MB SIGNATURE EVENT

Bio-Talent Summit

Nov. 11, 2025

Lansing, MI

INDUSTRY EVENT

AFCC Biobased Economy Conference and Exhibition

Nov. 16-18, 2025

Washington, D.C.

Two Expert-Led MichBio Webinars You Won’t Want to Miss!

Mark your calendar and join us for our upcoming webinars. Get expert insights, life sciences education, and the latest industry trends.

Learn, engage, and stay ahead!

Integrated Regulatory and Reimbursement Pathways for Commercial Acceleration

September 30, 2025 @ Noon

Presented by Lindsay Klee, Founder, Intent Venture Management^®

Patent Application Strategies: Drafting Tips. Filing Insights. Long-Term IP Success

October 15, 2025 @ Noon

Presented by Ashley Sloat, President, Director of Patent Strategy, Aurora Consulting and Kristen Pursley, Intellectual Patent Attorney/ Registered Patent Attorney, Dobrusin Law Firm